Frankfurt - Delayed Quote EUR
Q32 Bio Inc. (DB0.F)
1.5600
-0.0500
(-3.11%)
At close: April 25 at 3:49:30 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-67,715
-67,715
-18,677
-10,957
-32,979
Investing Cash Flow
19,925
19,925
-5
-2,466
-157
Financing Cash Flow
95,138
95,138
406
30,069
20,105
End Cash Position
78,612
78,612
31,264
49,540
32,984
Interest Paid Supplemental Data
856
856
422
--
--
Capital Expenditure
-75
-75
-5
-2,485
-157
Issuance of Capital Stock
42,000
42,000
--
--
19,990
Issuance of Debt
7,000
7,000
5,500
30,000
--
Repayment of Debt
--
--
-5,200
--
--
Free Cash Flow
-67,790
-67,790
-18,682
-13,442
-33,136
12/31/2021 - 7/9/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
2509.HK Qyuns Therapeutics Co., Ltd.
10.960
+3.59%
CLYM Climb Bio Inc
1.2700
-2.31%
EQ Equillium, Inc.
0.4382
-4.74%
HNSA.ST Hansa Biopharma AB (publ)
28.36
+19.76%
TVRD Tvardi Therapeutics, Inc.
18.85
+5.90%
SAGE Sage Therapeutics, Inc.
7.79
0.00%
FOLD Amicus Therapeutics, Inc.
7.35
+2.08%
AVTE Aerovate Therapeutics, Inc.
2.6800
-1.47%
XFOR X4 Pharmaceuticals, Inc.
0.1900
+1.50%
ONC BeiGene, Ltd.
244.90
-4.40%